Organisations
Ludwig Institute for Cancer Research
abbreviation: LICR
type: public research body
location: Melbourne, Victoria, Australia
WWW: www.ludwig.edu.au
description
The prospects for bringing cancer under control will only improve through an ongoing commitment to innovative basic and clinical research. In response, the Ludwig Institute for Cancer Research (LICR) engages leading scientists and clinicians in an integrated effort to understand and confront the global challenge of cancer. With nine Branches in seven countries across Australasia, Europe, and North and South America, and numerous Affiliates in many other countries, the scientific network that is LICR quite literally covers the globe. LICR is not only associated with established and distinguished academic institutions, but has also, through its James R. Kerr Program, expanded its activities into countries, such as China, Russia, Ukraine, South Africa, and Turkey, which are scientifically talented but have had little opportunity for international collaboration in cancer research.
The distinctiveness of LICR lies not only in its size and scale, but also in its philosophy and ability to drive its results from the laboratory into the clinic. The Institute has developed a substantial portfolio of reagents, knowledge, and expertise, and, unusually for an academic institution, has also actively assembled the personnel, facilities, and practices necessary to perform early-phase clinical trials. Thus LICR is able to translate the most promising aspects of its own research into cancer therapies. The Institute believes that the same science-driven investigative rigor that yielded the fundamental discoveries should, indeed must, be applied in the clinic to develop the therapeutic potential of any discovery. The goal of LICR is to make major contributions to the understanding and clinical management of cancer through its innovative structure and organization.
